Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
Investors Financing Lawsuits Presents Ethical Quagmire for Lawyers
June 17, 2009
investors finance lawsuits and reap any benefits - nytimes.com | www.nytimes.com
Under ethics rules governing lawyer conduct, a lawyer must exercise loyalty and independent judgment as essential elements in the lawyer-client relationship. In most jurisdictions, the legal ethics rules generally require a lawyer may not proceed if there are significant risks that the representation will be materially limited by the lawyer's personal interest(s). Also, such interest conflicts usually cannot be waived by a client's knowing consent unless, despite such conflict, the lawyer reasonably believes the lawyer will be able to provide competent and diligent representation and other of the ethics rules are followed. Because lawyers already have a financial interest in the outcome of litigation, piling on more financial interests could terminally affect a lawyer's ability to represent a client.
July 21, 2008
The Decline of the Mid-Market Cell Phone | www.businessweek.com
Mid-market cell phones and their brethren all have a big usability issue limiting their profitability: they are mostly not designed for the aging user, and such users represent a large market share. Take note, mobile industry execs, and evolve your product portfolios to leverage this untapped market.
Page : 11 to 2 of 2
Rising risks of an asset bubble in China threatened by US stagflation
November 7, 2009
Smarter Trash: How Incentive Programs Can Motivate Participation in Recycling
October 25, 2009
New Climate Change Bill Lacks Critical RPS for Renewables
October 7, 2009
China’s Anti-Monopoly Bureau Approves the Pfizer-Wyeth Transaction
September 29, 2009
Intellectual Property Right for Pharmaceutical Company
September 5, 2009